Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024

Rhea-AI Summary

Exagen Inc. (Nasdaq: XGN) will release financial results for Q4 and full year 2023 on March 18, 2024. Conference call with the CEO and CFO to review results on the same day at 8:30 AM ET. Webcast and replay details provided.

CARLSBAD, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter and year ended December 31, 2023, before the market opens on Monday, March 18, 2024. John Aballi, Exagen’s President and Chief Executive Officer, and Kamal Adawi, Chief Financial Officer, will host a conference call to review the Company’s results at 8:30 AM ET (5:30 AM PT).

Interested parties may access the conference call by dialing (201) 389-0918 (U.S.) or (877) 407-0890 (international). Participants wishing to access the call via webcast should use the link posted on the Exagen investor relations website at investors.exagen.com.

A replay of the conference call will be available until Monday, April 1, 2024, at 11:59 PM ET (8:59 PM PT). Interested parties may access the replay of the conference call by dialing (201) 612-7415 (U.S.) or (877) 660-6853 (international) using passcode 13743861. Additionally, a recording of the webcast will be available using the link on the Exagen investor relations website approximately one hour after the call concludes.

About Exagen Inc.

Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of improving patients’ clinical outcomes. Exagen is located in San Diego County, California.

For more information, please visit Exagen.com or follow @ExagenInc on X (formerly known as Twitter).

Contact:
Ryan Douglas
Exagen Inc.
ir@exagen.com
760.560.1525

FAQ

When will Exagen Inc. release its financial results for Q4 and full year 2023?

Exagen Inc. will release its financial results for the quarter and year ended December 31, 2023, on March 18, 2024.

Who will host the conference call to review Exagen Inc.'s financial results?

John Aballi, Exagen’s President and Chief Executive Officer, and Kamal Adawi, Chief Financial Officer, will host the conference call.

How can interested parties access the conference call?

Interested parties may access the conference call by dialing (201) 389-0918 (U.S.) or (877) 407-0890 (international) or via webcast on the Exagen investor relations website.

Until when will the replay of the conference call be available?

The replay of the conference call will be available until April 1, 2024, at 11:59 PM ET.

Where can interested parties find the recording of the webcast?

A recording of the webcast will be available on the Exagen investor relations website approximately one hour after the call concludes.